Monthly Archives: July 2016

In Vitro Toxicology Testing Market To Witness Enhanced Demand Based On Novel And Promising Technologies In Analytical Laboratories Till 2022

According to report published by Grand View Research, Inc , global in-vitro toxicology testing market is expected to reach $44.7 billion by 2022, growing preference for in-vitro toxicology tests over the conventional in-vivo tests is anticipated to drive demand in the sector.

San Francisco, California, United States – July 25, 2016 /MarketersMedia/ —

The global in-vitro toxicology testing market is expected to reach USD 44.7 billion by 2022 growing at an estimated CAGR of 10.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected rise in demand can be ascribed to novel and promising technologies in analytical laboratories.

Advancement in bioinformatics based research for development of efficient software algorithms in order to carry out efficient stimulation of in-silico animal models in determination of toxicological response is expected to influence sector growth through to 2022.

Furthermore, rapid up gradation of databases that serve information for toxicity profiling and lethal dose determination of different compounds is anticipated to create significant potential for growth in this market during the forecast period.

Rise in government imposed restrictions and guidelines on usage of animals for pre-clinical research and toxicology testing is also attributive towards estimated progress in this industry.

Additionally, increasing R&D in biotechnology sector for enhancement in cell based assays and cell culture techniques, is anticipated to impart significant growth potential in this sector.

Access full research report: http://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market

Key findings

• Pharmaceutical and cosmetic industry together accounted for almost 65% of total revenue generated in this sector for 2014. This large share can be attributed to rapid novel product launches for treatment of different diseased conditions wherein toxicological testing is the pre-requisite step.
• Cell culture technology contributed for over 42% of the revenue generated in the industry with respect to technology owing to critical role of cell culture in biotechnological development and cell based analysis
• Omics technology is anticipated to register lucrative growth thereby driving demand due to advancement in sequencing methods and availability of different platforms depending on source and target sequence.
• As a fundamental process in biopharmaceutical or pharmaceutical product development toxicological testing finds application in determination of systemic, dermal, & ocular toxicity as well as endocrine disruption
• Amongst the above enlisted applications, dermal toxicity is expected to witness significant progress with a CAGR of approximately 13% due to comparatively higher incidence of side effects associated with skin after administration of several compounds.
• North America accounted for the largest share of over 45% in revenue in 2014 owing to presence of significant number of sector players that are implementing advanced in-vitro technology. Furthermore, presence of stringent regulations pertaining to animal usage in toxicity analysis attributive towards high demand of in-vitro tests in this region.
• Asia Pacific is expected to witness lucrative CAGR of over 11% from 2015 to 2022 due to rapid improvement in health care infrastructure in developing economies of this region which in turn contributes to regional progress in industry.
• Key participants of in-vitro toxicology testing industry are Quest Diagnostics, Covance, Cyprotex, Alere, Inc, Charles River Laboratories, GE Healthcare, Thermo Fisher Scientific, Eurofins Scientific, Inc., Agilent Technologies, Catalent Pharma Solutions, Sigma Aldrich, and Bio-Rad.
• These participants are involved in collaborations with bioinformatics research firms in order to develop novel in-silicoalgorithms for computational estimation of toxicity of pharmaceutical and chemical products.
• Moreover, these market entities are also focusing on entering untapped regions in order to maintain their share in market revenue.

Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market/request

Market Segments:

Outlook, by End-use (Revenue, USD Million, 2012 – 2022)
• Pharmaceutical industry
• Cosmetics & household products
• Diagnostics
• Chemical industry
• Food industry
Technology Outlook (Revenue, USD Million, 2012 – 2022)
• Cell culture technology
• High throughput technology
• Molecular imaging
• OMICS technology
Outlook, by Application (Revenue, USD Million, 2012 – 2022)
• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Occular toxicity
Outlook, by Method (Revenue, USD Million, 2012 – 2022)
• Cellular Assay
• Biochemical Assay
• In-Silico
• Ex-vivo
Regional Outlook (Market Revenue in USD Million, 2012 – 2022 )
• North America
• Europe
• Asia Pacific
• RoW

Access press release of this research report: http://www.grandviewresearch.com/press-release/global-in-vitro-toxicology-testing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market

Contact Info:
Name: Sherry James
Email: sales@grandviewresearch.com
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/in-vitro-toxicology-testing-market-to-witness-enhanced-demand-based-on-novel-and-promising-technologies-in-analytical-laboratories-till-2022/124915

Release ID: 124915

Easy Anti Aging: Maple Holistics Introduces Apricot Seed Oil For Anti Aging

Maple Holistics has announced the launch of their Apricot Seed Oil, the latest in the Maple Holistics personal care products line. The Apricot Seed Oil is available for purchase through MapleHolistics.com.

Lakewood, USA – July 25, 2016 /PressCable/ —

Maple Holistics has introduced a new product to its highly successful and acclaimed line of all-natural personal care products: Apricot Seed Oil for skin, hair, and anti-aging. Available for purchase now through the Maple Holistics website, the Apricot Seed Oil is one of the best carrier and massage oils for sensitive skin, featuring medium viscosity and easy blend with other essential oils.

Boasting a moderately long shelf life, Maple Holistics Apricot Seed Oil absorbs easily into the skin. It is one of the most popular aromatherapy oils available because it can be effectively mixed with other ingredients. Ideal for massage or aromatherapy experiences, the 100% Pure Apricot Oil is perfect for use on the face, skin, nails, and hair. It contains vitamins A, B, C, and E, as well as a large amount of antioxidants which work together to help moisturize and prevent free radical damage. Apricot seed oil is light enough for everyday use and will not cause buildup or weigh down hair. It also contains a large amount of Omega 6 fatty acids and vitamin E, which studies have shown can stimulate hair growth and promote scalp wellbeing.

The oil contains no silicone or sulfate ingredients, which is safest for color treated hair. The oil is cruelty-free, paraben-free, hypoallergenic, made in the USA, contains no artificial colors or harmful ingredients, and is packaged in environmentally friendly, BPA-free bottles.

One of the best ways to prevent premature aging is to neutralize the free radicals that cause cell damage. Apricot Seed Oil contains a large antioxidant profile which allows it to effectively neutralize free radicals. The presence of vitamins A (retinol), C, and E may help further protect cell membranes from free radicals. This may help reduce sun damage that causes wrinkles and fine lines.

The release of Maple Holistics Apricot Seed Oil follows the successful launch of Maple Holistics’ Argan Oil, Avocado Oil, Eucalyptus Essential Oil, Grapeseed Oil, and other acclaimed all-natural personal care products. Maple Holistics personal care products make up one part of its multi-faceted line of natural products which boast the purest and highest quality ingredients used in each product, maximizing the therapeutic potential for each specific area of health.

About the Company

Maple Holistics provides industry leading, all-natural hair, body, and skin products. The company offers a natural, holistic range of premium products which can enhance hygiene, health and daily living. Company products are made in the USA.

For more information, please visit https://www.mapleholistics.com/

Contact Info:
Name: Nate M
Organization: Maple Holistics

Release ID: 124510

Global Absorption Chiller Market Growth And Forecast For 2016-2021 By Radiant Insights, Inc

This report has been prepared based on the synthesis, analysis, and interpretation of information about the global Absorption Chiller market collected from specialized sources.

San Francisco, United States – July 25, 2016 /MarketersMedia/ —

This report provides detailed analysis of worldwide markets for Absorption Chiller from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Absorption Chiller market and further lays out an analysis of the factors influencing the supply/demand for Absorption Chiller, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Browse Full Research Report With TOC:
http://www.radiantinsights.com/research/global-absorption-chiller-market-outlook-2016-2021

An Absorption Chiller is a machine uses a heat source to generate chilled water rather than electrical source that is used in vapor compression cycle. It’s an attractive idea to produce chilled water with heat. The major difference between a vapor compression system and an absorption chiller is that a vapor compression system using a compressor to make the pressure difference required to circulate the refrigerant while the absorption chiller using heat. The absorption chiller is very attractive because using energy in the form of heat, such as solar or waste heat, makes it using a little work input and saving in money. Also it can works with industrial waste heat streams.

See More Reports of This Category by Radiant Insights:
http://www.radiantinsights.com/catalog/equipment

GCC’s report, Global Absorption Chiller Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Absorption Chiller market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Absorption Chiller market areTrane (USA), Ebara (Japan), HITACHI (Japan), Panasonic (Japan), Kawasaki Thermal Engineering (Japan), LG (Korea), Century (Korea), Carrier (USA), Thermax (India), Shuangliang (China), Yantai Ebara (China), Broad Group (China), Dalian Panasonic (China), Hope Deepblue (China).

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Absorption Chiller industry has been provided.

Request A Sample Copy Of This Report at:
http://www.radiantinsights.com/research/global-absorption-chiller-market-outlook-2016-2021/request-sample

About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, please visit http://www.radiantinsights.com/research/global-absorption-chiller-market-outlook-2016-2021

Contact Info:
Name: Michelle Thoras
Email: sales@radiantinsights.com
Organization: Radiant Insights, Inc
Address: 28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054

Source: http://marketersmedia.com/global-absorption-chiller-market-growth-and-forecast-for-2016-2021-by-radiant-insights-inc/124927

Release ID: 124927

Weight Loss And Diet Products Market Growth And Opportunities In China: Radiant Insights, Inc

The global weight loss and diet products market are growing at the significant pace over the forecast period (2018-2023). The industry has observed high demand in the past decade.

San Francisco, United States – July 25, 2016 /MarketersMedia/ —

The global weight loss and diet products market are growing at the significant pace over the forecast period (2018-2023). The industry has observed high demand in the past decade. Both demand and production of weight loss equipments and diet products will expand in the coming years. Rise in the obese population, lifestyle changes, and strong government funding and support is likely to spur the demand. Emerging regions are anticipated to experience rapid adoption of weight loss and diet products further.

Weight loss meal replacements and dietary supplements are progressively sold via online distribution, direct distribution, and health & beauty stores. Hypermarkets and supermarkets are chief distribution channels for better-for-you food & beverages. Also, small retail formats such as grocery stores and departmental stores are growing to compete with big scale set-ups.

Browse Full Research Report With TOC on
http://www.radiantinsights.com/research/weight-loss-and-diet-product-markets-in-china

Technological advancements along with augmenting membership for health clubs have amplified the growth. The global market is sliced into diets, equipments, services, and regions. Diets include supplements, equipments, and meals. Meals encompass low-calorie sweeteners, meal replacements, and low -calorie diet. Supplements are green tea extract, protein, fiber, and conjugate linoleic acid. Meals replacements are expanding at the healthy CAGR over the review period.

Key equipments are surgical, noninvasive, and fitness. Fitness equipment comprises strength training and cardiovascular training equipment. Surgical equipments are noninvasive and minimally invasive.

Request A Sample Copy Of This Report at:
http://www.radiantinsights.com/research/weight-loss-and-diet-product-markets-in-china/request-sample

Services in the global industry are fragmented into online weight loss programs, slimming centers, fitness centers, and consulting services. On the basis on geographies, the global weight loss, and diet products market is split into North America, Asia, Europe, and Rest of the World (RoW).

North America consumed for the highest shares globally. Asia Pacific is projected to attain notable volumes in the coming years. China is projected to be the leading country. Expanding diabetic and obese population is expected to attribute to regional growth.
Escalating disposable income, lower cost of bariatric surgeries and sedentary lifestyles could endorse medical tourism in this region. This will positively affect the total industry growth. Key manufacturers in overall weight loss and diet products market encompass Kellogg Company, Atkins Nutrionals, Herbalife, and NutriSytems. Herbalife products are vastly sold in the global market.

Browse All Reports of This Category at:
http://www.radiantinsights.com/catalog/food

About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, please visit http://www.radiantinsights.com/research/weight-loss-and-diet-product-markets-in-china

Contact Info:
Name: Michelle Thoras
Email: sales@radiantinsights.com
Organization: Radiant Insights, Inc
Address: 28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054

Source: http://marketersmedia.com/weight-loss-and-diet-products-market-growth-and-opportunities-in-china-radiant-insights-inc/124929

Release ID: 124929

China’s Cosmetics Market Research And Analaysis Report By Radiant Insights, Inc

China’s cosmetic market has been experiencing lucrative growth in the recent past. Retail sales of cosmetics in the nation are projected to exceed RMB 240 billion in 2017. The market is expected to continue its growth trajectory from 2018 to 2023.

San Francisco, United States – July 25, 2016 /MarketersMedia/ —

China’s cosmetic market has been experiencing lucrative growth in the recent past. Retail sales of cosmetics in the nation are projected to exceed RMB 240 billion in 2017. The market is expected to continue its growth trajectory from 2018 to 2023. This may be attributed to rising focus on physical appearance. Modern consumers are in constant pursuit of beauty. Well-developed distribution channels offer the necessary support for market growth. Rapidly growing demand from Tier II and Tier III cities is expected to open new avenues for sale of cosmetics in the coming years.

Browse Full Research Report With TOC on
http://www.radiantinsights.com/research/cosmetics-markets-in-china

On the basis of products, the market is divided into skincare, hairdressing, beauty, color cosmetics, and perfumes. Skincare holds a considerable share of the total market. Out of the total revenues in 2013, skincare accounted for 48%. Males are emerging as an important consumer segment. This has fueled introduction of various products suitable for them.

Hairdressing may witness stagnant growth in the forthcoming years. Perfumes are highly-demanded in large cities. Experts foresee high consumption of mid-priced and top-end products owing to the expanding disposable earnings and rising awareness of regular skincare.

China’s cosmetics market is characterized by stiff competition. This is the result of an influx of global brands and the emergence of domestic vendors, all vying for business from the most populous country in the world. Domestic companies account for a lower portion of the total market as compared to other regions like the U.S., and Japan.

Request A Sample Copy Of This Report at:
http://www.radiantinsights.com/research/cosmetics-markets-in-china/request-sample

Regional participants lack the necessary research & development capabilities, and a clear positioning in the market. Their products are popular in remote areas that are untapped by foreign brands. Retail stores are the major distribution channels in the overall market. However, revenues from the internet are on the rise.

Some of the reputed brands in China’s Cosmetics Market are Clinique, Lancome, Sasa, Jumei, Yoka, and Lamer. Global players need to adapt their offerings according to Chinese regulations governing the industry. China’s cosmetic regulations are complicated. Products are granted the Cosmetics Production Permit following approval by The China Food and Drug Administration (CFDA). Rising emphasis on protection of consumer rights has increased pressure on cosmetic companies to ensure product quality and safety.

Browse All Reports of This Category at:
http://www.radiantinsights.com/catalog/personal-care

About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, please visit http://www.radiantinsights.com/research/cosmetics-markets-in-china

Contact Info:
Name: Michelle Thoras
Email: sales@radiantinsights.com
Organization: Radiant Insights, Inc
Address: 28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054

Source: http://marketersmedia.com/chinas-cosmetics-market-research-and-analaysis-report-by-radiant-insights-inc/124931

Release ID: 124931

Hemodynamic Monitoring Devices Market To Gain From Enhanced Demand For Non-Invasive Monitoring Techniques Till 2024: Grand View Research, Inc.

According to report published by Grand View Research, Inc., global hemodynamic monitoring devices market will be worth $1.4 billion by 2024, increasing incidences of lifestyle-related conditions such as diabetes, obesity, stroke, and hypertension, are expected to be the principal drivers of the market.

San Francisco, California, United States – July 25, 2016 /MarketersMedia/ —

The global hemodynamic monitoring devices market is expected to reach USD 1.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for non-invasive monitoring techniques coupled with the rising prevalence of chronic illness is expected to drive the market over the forecast period.

The hemodynamic monitoring market is influenced by new technologies such as echocardiography, thoracic electrical bio-impedance and others that maybe used to non-invasively monitor parameters such as cardiac output, arterial pressure, blood oxygen level, and central venous pressure.

Furthermore, the rising population of critically ill patients coupled with defective healthcare facilities with drawbacks, such as understaffing, is propelling market players to develop minimal invasive hemodynamic monitoring devices that may be used in clinical and home care settings. Along with the new product development, the market is also anticipated to witness the development of technologies that help in the early diagnosis of shock and sepsis.

Furthermore, efforts by key industry players to understand critical illnesses at molecular levels leading to the development of efficient assessment products are expected to be witnessed over the forecast period. Hence, all these company strategies and the research conducted are eventually expected to promote market growth over the forecast period.

Access full research report: http://www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market

Key findings

• The disposables segment is anticipated to be the largest segment by 2024. The rising sale of hemodynamic monitoring systems and increasing applications of these systems in home care settings, hospitals, and clinics are expected to boost the segment growth.
• The non-invasive devices segment is expected to be the fastest growing hemodynamic monitoring market. Risks that include the development of arrhythmias due to the use of pulmonary artery catheter and the development of other methodologies that measure the cardiac output, such as echocardiographs, are the vital impact rendering drivers.
• Asia Pacific is anticipated to be the fastest growing regions and is anticipated to contribute to about 20.0% of the global revenue by 2024. The strengthening of the distribution channels by companies and the registration of products in countries, such as China, India, Australia, and others, are expected to support the growth over the forecast period. For instance, LiDCO Group, in their 2016 prelim report emphasized on its strategy of appointing new distributors for the Australian and South East Asian region.
• Major industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical, Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc., Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical, Inc. As mentioned above, the new product development is expected to drive the market over the forecast period.
• For instance, in March 2016, the LiDCO Group received the U.S. FDA approval for the LiDCO unity and launched the product in the European region. Along the same time, LiDCO also succeeded in registering itself in China to explore untapped territories and increase their global presence.

Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market/request

Market Segments:

Product Outlook (Revenue, USD Million, 2014 – 2024)
• Monitoring systems
• Pulmonary artery catheters
• Cardiac output monitors
• Others
• Disposables
• Probes
• Airflow Sensors
• Circuits
• Others
• Services
Type Outlook (Revenue, USD Million, 2014 – 2024)
• Invasive Hemodynamic Monitoring System
• Minimally Invasive Hemodynamic Monitoring System
• Non-invasive Hemodynamic Monitoring System
End-use Outlook (Revenue, USD Million, 2014 – 2024)
• Hospitals
• Catheterization Laboratories
• Others
Regional Outlook (Revenue, USD Million, 2014 – 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Saudi Arabia

Access press release of this research report: http://www.grandviewresearch.com/press-release/global-hemodynamic-monitoring-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market

Contact Info:
Name: Sherry James
Email: sales@grandviewresearch.com
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/hemodynamic-monitoring-devices-market-to-gain-from-enhanced-demand-for-non-invasive-monitoring-techniques-till-2024-grand-view-research-inc/124919

Release ID: 124919

INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Inovalon Holdings, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against Inovalon Holdings, Inc. (“Inovalon” or the “Company”) (NASDAQ: INOV). Investors who purchased or otherwise acquired shares on or about the February 12, 2015 initial public offering (“IPO”) date, are encouraged to contact the Firm prior to the August 23, 2016, lead plaintiff motion deadline.

If you purchased shares of Inovalon on or about the IPO date, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that Inovalon’s Registration Statement issued in connection with the IPO failed to disclose material facts and contained misleading and/or false statements. The Company did not disclose that it receives substantial revenues from sales in New York City and New York State, both of which were pushing to obtain more taxes from out-of-state businesses like Inovalon. The corporate tax rate increases were implemented on January 1, 2015. This increase significantly raised Inovalon’s effective tax rate, and lowered the Company’s 2015 earning potential. When this news was released, the Company’s common stock value dropped significantly, causing investors harm.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 442756

IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against TransEnterix, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against TransEnterix, Inc. (“TransEnterix” or the “Company”) (NYSE MKT: TRXC). Investors who purchased or otherwise acquired shares between February 10, 2016 and May 10, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the August
1, 2016 lead plaintiff motion deadline.

If you purchased shares of TransEnterix during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that, throughout the Class Period, TransEnterix made false and/or misleading statements and/or failed to disclose that: there were deficiencies within the Company’s 510(k) submission regarding the SurgiBot that undermined the likelihood that the SurgiBot would receive clearance from the Food and Drug Administration, which would leave TransEnterix unable to commercialize the SurgiBot in 2016, and would impair the Company’s ability to obtain approval for and commercialize its other robotic surgery platform in the United States.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 442761

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Chiasma, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 25, 2016 / Lundin Law PC (the “Firm”) announces that a class action lawsuit was filed against Chiasma, Inc. (“Chiasma” or the “Company”) (NASDAQ: CHMA) concerning possible violations of federal securities laws between July 15, 2015 and April 17, 2016 (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion
deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

The complaint alleges that Chiasma made materially false and/or misleading statements about the Company’s business during the Class Period. The Company failed to disclose that the Phase 3 clinical trial for its oral octreotide, Mycapssa, which was conducted before the July 15, 2015 IPO, was insufficient to prove efficacy and secure FDA approval. Also Chiasma’s supervision of its suppliers was not sufficient enough to prevent deficiencies that delayed FDA approval of Mycapssa. On April 18, 2016 the Company announced that the FDA issued a Complete Response Letter, in response to the Company’s New Drug Application for Mycapssa, stating that the FDA did not believe the application provided sufficient evidence of efficacy to warrant approval, another clinical trial would be necessary, and that deficiencies with the Company’s suppliers would need to be resolved. When Chiasma announced this information on April 18, 2016 the share price fell 63.13% on that day.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 442762

DEADLINE TODAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tangoe, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against Tangoe, Inc. (“Tangoe” or the “Company”) (NASDAQ: TNGO). Investors who purchased or otherwise acquired shares between March 18, 2014 and March 7, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm by the July 25, 2016 lead plaintiff motion deadline.

If you purchased shares of Tangoe during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that Tangoe issued false and misleading information and or/failed to disclose that: The Company made errors in recognizing its revenue; Tangoe’s financial results were overstated; and as a result of the above, statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When this news was released, investors suffered losses.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

KHANG & KHANG LLP

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP 

ReleaseID: 442759